Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1979 Oct;26(1):118–124. doi: 10.1128/iai.26.1.118-124.1979

Passage of Pseudomonas aeruginosa in compromised mice.

C D Cox
PMCID: PMC414582  PMID: 115795

Abstract

There was no appreciable increase in the virulence of Pseudomonas aeruginosa PAO-1 after six passes through infections in mice. When strain PAO-1 was passed through mice compromised with iron and methotrexate, the virulence of the passed bacteria increased for normal as well as compromised mice. Bacteria harvested from intraperitoneal passage in compromised mice were more virulent than bacteria harvested from intrathoracic passage. These bacteria expressed 50% lethal dose values distinctive of the respective bacterial isolate when injected intraperitoneally, intrathoracically, or intravenously. Differences between bacteria from intraperitoneal and intrathoracic passage were apparently due to differences in the selective pressures in the two sites of infection, because the intrathoracically passed bacteria assumed the virulence characteristics of the intraperitoneally passed bacteria after intraperitoneal passage in compromised mice.

Full text

PDF
119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bobo R. A., Newton E. J., Jones L. F., Farmer L. H., Farmer J. J., 3rd Nursery outbreak of Pseudomonas aeruginosa: epidemiological conclusions from five different typing methods. Appl Microbiol. 1973 Mar;25(3):414–420. doi: 10.1128/am.25.3.414-420.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bullen J. J., Ward C. G., Wallis S. N. Virulence and the role of iron in Pseudomonas aeruginosa infection. Infect Immun. 1974 Sep;10(3):443–450. doi: 10.1128/iai.10.3.443-450.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Feingold D. S. Hospital-acquired infections. N Engl J Med. 1970 Dec 17;283(25):1384–1391. doi: 10.1056/NEJM197012172832507. [DOI] [PubMed] [Google Scholar]
  4. Fishman L. S., Armstrong D. Pseudomonas aeruginosa bacteremia in patients with neoplastic disease. Cancer. 1972 Sep;30(3):764–773. doi: 10.1002/1097-0142(197209)30:3<764::aid-cncr2820300326>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  5. Forsberg C. M., Bullen J. J. The effect of passage and iron on the virulence of Pseudomonas aeruginosa. J Clin Pathol. 1972 Jan;25(1):65–68. doi: 10.1136/jcp.25.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gibson J. J., Jr, Brodsky R. E., Schultz M. G. Changing patterns of malaria in the United States. J Infect Dis. 1974 Nov;130(5):553–555. doi: 10.1093/infdis/130.5.553. [DOI] [PubMed] [Google Scholar]
  7. HOLLOWAY B. W. Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol. 1955 Dec;13(3):572–581. doi: 10.1099/00221287-13-3-572. [DOI] [PubMed] [Google Scholar]
  8. Jones L. F., Zakanycz J. P., Thomas E. T., Farmer J. J., 3rd Pyocin typing of Pseudomonas aeruginosa: a simplified method. Appl Microbiol. 1974 Feb;27(2):400–406. doi: 10.1128/am.27.2.400-406.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. LIU P. V., MERCER C. B. GROWTH, TOXIGENICITY AND VIRULENCE OF PSEUDOMONAS AERUGINOSA. J Hyg (Lond) 1963 Dec;61:485–491. doi: 10.1017/s0022172400021100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pruitt B. A., Jr Infections caused by Pseudomonas species in patients with burns and in other surgical patients. J Infect Dis. 1974 Nov;130 (Suppl)(0):S8–13. doi: 10.1093/infdis/130.supplement.s8. [DOI] [PubMed] [Google Scholar]
  11. Weinberg E. D. Iron and susceptibility to infectious disease. Science. 1974 May 31;184(4140):952–956. doi: 10.1126/science.184.4140.952. [DOI] [PubMed] [Google Scholar]
  12. Young V. M., Moody M. R. Serotyping of Pseudomonas aeruginosa. J Infect Dis. 1974 Nov;130 (Suppl)(0):S47–S52. doi: 10.1093/infdis/130.supplement.s47. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES